EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy and safety of topical cream containing aminoacryl tRNA synthetase complex interacting 1-derived peptide in mitigating radiation dermatitis after adjuvant radiotherapy for breast cancer

Hye Sung Han, Young Gue Koh, Ka Ram Kim, Jin Hwa Choi, Kui Young Park

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-025-09147-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Hye Sung Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Gyeonggi-do, Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiodermatitis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CGBio Co. Ltd., Chung-Ang University Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Acute radiation dermatitis (ARD) is a frequent side effect experienced by breast cancer patients undergoing radiotherapy. This study aimed to assess the efficacy and safety of a topical cream containing aminoacryl tRNA synthetase complex interacting 1 (AIMP1)-derived peptide (AdP) in mitigating radiation dermatitis (RD) in breast cancer patients undergoing radiotherapy. METHODS: An 8-week single-center, prospective pilot study was conducted to compare the clinical efficacy and safety of an AdP-containing cream with a control cream lacking AdP for the mitigation of RD. Fifteen patients undergoing radiotherapy applied the test cream to the right side and the control cream to the left side of the radiation exposure site, bisected by the nipple line. RD was evaluated at baseline and at weeks 2, 4, 6, and 8, employing the 5-point grading system advocated by the Radiation Oncology Group (RTOG). RESULTS: The average RTOG score was lower on the test side in comparison to the control side, and a less pronounced increase in melanin index was observed on the test side. However, these differences were not statistically significant. Both sides exhibited increased skin hydration and decreased transepidermal water loss. Analyzing the maximum RTOG scores throughout the study, RD of maximum grades 1 and 2 was noted in 54.5% and 45.5% of patients on the test side. On the control side, the maximum grades 1 and 2 were observed in 45.5% and 54.5% of patients respectively. CONCLUSION: The AdP-containing cream did not prove to be more effective than the control cream without AdP in mitigating RD. However, the total incidence of RD in our study was notably lower than previously documented, illustrating the protective effects of both the test and control creams.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRadiodermatitisHumansFemaleMiddle AgedPilot ProjectsProspective StudiesAgedRadiotherapy, AdjuvantSkin CreamAdultAdministration, TopicalTreatment Outcome

Stichwörter der Autor:innen

AIMP1-derived peptide (AdP)Breast cancerRadiation dermatitis (RD)Topical cream

Autor:innen und Institutionen

  • Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Gyeonggi-do, Korea.
  • Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
  • Department of Dermatology, Chung-Ang University Hospital, Heukseok-ro 102, Dongjak-ku, Seoul, 06973, South Korea.
  • Department of Radiation Oncology, Chung-Ang University College of Medicine, Seoul, Korea.
  • Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea. kyky@cauhs.or.kr.
  • Department of Dermatology, Chung-Ang University Hospital, Heukseok-ro 102, Dongjak-ku, Seoul, 06973, South Korea. kyky@cauhs.or.kr.

Förderung

  • CGBio Co. Ltd.
  • Chung-Ang University Medical Center

Zitieren

APA

Han, H. S., Koh, Y. G., Kim, K. R., Choi, J. H., & Park, K. Y. (2025). Efficacy and safety of topical cream containing aminoacryl tRNA synthetase complex interacting 1-derived peptide in mitigating radiation dermatitis after adjuvant radiotherapy for breast cancer. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09147-9

Vancouver

Han HS, Koh YG, Kim KR, Choi JH, Park KY. Efficacy and safety of topical cream containing aminoacryl tRNA synthetase complex interacting 1-derived peptide in mitigating radiation dermatitis after adjuvant radiotherapy for breast cancer. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09147-9

BibTeX
@article{Han2025,
  author = {Han, Hye Sung and Koh, Young Gue and Kim, Ka Ram and Choi, Jin Hwa and Park, Kui Young},
  title = {Efficacy and safety of topical cream containing aminoacryl tRNA synthetase complex interacting 1-derived peptide in mitigating radiation dermatitis after adjuvant radiotherapy for breast cancer},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-025-09147-9}
}
Kostenlos starten →